A New Chemiluminescence Immunoassay for Phospholipase A2 Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy

A New Chemiluminescence Immunoassay for Phospholipase A2 Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy

Background: Circulating autoantibodies against the M-type phospholipase A2 receptor 1 (PLA2R1) are important biomarkers in membranous nephropathy (MN), supporting the diagnosis and the clinical monitoring of patients. Standardized recombinant cell-based indirect immunofluorescence assay (RC-IFA) and...

Full description

Bibliographic Details
Main Authors: Elion Hoxha, Rolf A.K. Stahl, Linda Reinhard, Alexander Kühnl, Wolfgang Schlumberger, Cornelia Dähnrich
Format: Article
Language:English
Published: Elsevier 2021-04-01
Series:Kidney International Reports
Subjects:
chemiluminescence immunoassay
membranous nephropathy
phospholipase A2 receptor 1
PLA2R1-ab
renal autoimmune diseases
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024920318684

Internet

http://www.sciencedirect.com/science/article/pii/S2468024920318684

Similar Items